iFOREX Shares Frozen in Place Three Weeks After London Debut

Trading in iFOREX Financial Trading Holdings has been dormant for two weeks on the London Stock Exchange, a silence growing increasingly conspicuous. The CFD broker, which listed on the LSE Main Market on February 25 after an eight-month delay, sits at around 207 pence per share, roughly 6% above its 195p offer price, a figure that conveys little useful information to investors.

The arithmetic of the listing is straightforward. iFOREX priced its IPO at 195 pence, issuing 4.487 million new ordinary shares representing just 20.2% of total share capital, with no existing shareholders selling down. The raise totaled £8.75 million against a £43.3 million valuation. This leaves only one-fifth of the company available to trade, and institutional investors in the placing are typically expected not to sell quickly. Founder Eyal Carmon, who holds 58.91% post-listing, along with directors and senior managers, agreed to a 12-month lock-up. The result is a stock with minimal tradeable supply, where a single motivated buyer or seller could move the price significantly, deterring cautious investors.

The first day of trading showed promise, with shares opening above the offer price and rising roughly 6% on post-IPO enthusiasm. CEO Itai Sadeh called the listing "a pivotal moment in iFOREX's evolution," citing an oversubscribed placing. However, that momentum evaporated quickly. Volume dried up within days, and by early March, shares were effectively frozen. No analysts cover the stock, no major institutions have disclosed positions, and its market cap of just over £46 million is below the threshold for meaningful attention from UK equity fund managers.

Financials published ahead of the listing provided little excitement. iFOREX reported 2025 revenue of $48.8 million, slightly below 2024's $50.1 million. Adjusted EBITDA is expected around $4 million, down sharply from $9.7 million the prior year. First-half 2025 net profit was just over $1.2 million, a 63.5% year-on-year drop. The company attributed weakness to low Q3 volatility and IPO timeline uncertainty, acknowledging in its prospectus that a "short-term revenue initiative" was ineffective. A structural concern remains: over 95% of revenue comes from its British Virgin Islands-regulated entity, with the rest from Cyprus. The broker operates in Japan, India, and the Middle East without local licenses, relying on reverse solicitation arrangements increasingly questioned by regulators.

A comparison with eToro is instructive. eToro's US IPO last year achieved a multi-billion dollar valuation, was 10 times oversubscribed, and attracted institutional interest. While its shares have faced pressure, it maintains an active market. iFOREX's IPO, by contrast, raised less than $11 million and trades on an LSE Main Market where the broader IPO pipeline has been weak. The LSE has been losing ground to New York, and smaller listings often fade from view quickly.

For iFOREX shares to gain traction, the company must deliver financial results surpassing its underwhelming 2025 figures, secure at least one targeted regulatory license in markets like Australia or the UK, and attract a market maker or analyst to promote the stock to new investors.